Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.
Condition: SmallpoxIntervention: Biological: IMVAMUNE (MVA-BN)Sponsors: Bavarian Nordic; National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Infectious Diseases | Research | Smallpox | Smallpox Vaccine | Study | Vaccines